NCT06651970 2026-02-23
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
Phase 4 Recruiting
AstraZeneca
University Health Network, Toronto
Silesian Centre for Heart Diseases
University of Sao Paulo
Second Affiliated Hospital, School of Medicine, Zhejiang University